Lexaria Bioscience Corp. (LEXX)
0.7368
-0.02
(-2.90%)
USD |
NASDAQ |
Jan 20, 11:06
Lexaria Bioscience Total Assets (Quarterly): 6.051M for Nov. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 10.82M |
| Aurinia Pharmaceuticals, Inc. | 527.53M |
| Edesa Biotech, Inc. | 13.66M |
| Xenon Pharmaceuticals, Inc. | 607.84M |
| ProMIS Neurosciences, Inc. | 21.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.527M |
| Shareholders Equity (Quarterly) | 4.913M |
| Debt to Equity Ratio | 0.0207 |
| Current Ratio | 3.682 |
| Net Debt Paydown Yield | 0.03% |